Norway represents one of the most sophisticated healthcare markets globally, driven by a decentralized yet highly integrated public health system (Helseforetak). As a leading Laboratory Molecular Testing Solutions Supplier for Norway, we recognize that the Norwegian market demands more than just equipment; it requires compliance with EU IVDR regulations, seamless integration with Laboratory Information Systems (LIS), and robust performance in extreme geographical conditions.
Global molecular diagnostics is shifting toward "Precision Medicine" and "Point-of-Care Testing (POCT)". In Norway, where the population is distributed across vast distances—from Oslo to Tromsø—the need for automated nucleic acid testing platforms that can operate with minimal supervision is paramount. Our solutions bridge the gap between high-volume central labs and regional clinical facilities, providing decentralized testing capabilities without compromising on the sensitivity of RT-PCR or NGS (Next-Generation Sequencing) workflows.
Shenzhen BioX Medical ensures that all molecular solutions meet the rigorous Norwegian Medicines Agency (NoMA) and European Union standards. Our technical roadmap focuses on the "Green Lab" initiative, reducing plastic waste in PCR consumables and optimizing power consumption—aligning with Norway's sustainability goals. We provide specialized training for Norwegian laboratory technicians, ensuring that the transition to our automated systems is seamless and efficient.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
The evolution of molecular testing in Norway is moving toward Full Laboratory Automation and AI-Driven Diagnostic Insights. Our R&D focus for the Norwegian market includes:
Our molecular diagnostic systems are CE-IVD marked and undergo rigorous quality control to meet the European In Vitro Diagnostic Regulation (IVDR 2017/746), which is the standard followed in Norway. We provide full documentation for lab accreditation (ISO 15189).
Yes, we offer both remote digital diagnostics for our machines and localized on-site support through our network of certified Nordic distributors and service engineers.
Our systems feature open API architectures and HL7 protocol compatibility, allowing seamless integration with the various Laboratory Information Systems used across Norway's Regional Health Authorities.
Typically, standard equipment is shipped within 4-6 weeks, while customized OEM/ODM solutions follow a structured 12-week timeline from design finalization to delivery.
Absolutely. All chemical products supplied to the Norwegian industrial or laboratory sectors are fully compliant with REACH regulations and come with comprehensive Safety Data Sheets (SDS).
Join hundreds of laboratories across Europe and Norway that trust Shenzhen BioX Medical for precision, reliability, and innovation. Contact us today for a technical consultation or to request a quote for your specific laboratory needs.
Send Inquiry Now
BioX Medical
